Compound ID | 587
Class: Immunomodulator
| Spectrum of activity: | Gram-positive |
| Details of activity: | An anti-tubercular compound. |
| Description: | Jagannath C, Allaudeen HS, Hunter RL and Emanuele. Activity of CRL-1018 against drug resistant strains of Mycobacterium tuberculosis in vitro and in vivo. 35th-Intersci-Conf-Antimicrobial-Agents-Chemother 1995; 117 |
| Institute where first reported: | CytRX Corporation, USA (LadRx) |
| Year first mentioned: | 1995 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |